ShopSpell

Targeting Cellular Signalling Pathways in Lung Diseases [Hardcover]

$136.99     $199.99    32% Off      (Free Shipping)
100 available
  • Category: Books (Medical)
  • ISBN-10:  9813368268
  • ISBN-10:  9813368268
  • ISBN-13:  9789813368262
  • ISBN-13:  9789813368262
  • Publisher:  Springer
  • Publisher:  Springer
  • Binding:  Hardcover
  • Binding:  Hardcover
  • Pub Date:  01-Apr-2021
  • Pub Date:  01-Apr-2021
  • SKU:  9813368268-11-SPRI
  • SKU:  9813368268-11-SPRI
  • Pages:  926
  • Pages:  926
  • Item ID: 105006432
  • List Price: $199.99
  • Seller: ShopSpell
  • Ships in: 5 business days
  • Transit time: Up to 4 business days
  • Delivery by: Oct 02 to Oct 04

The book comprehensively reviews and provides detailed insight into the cellular and molecular signalling mechanisms involved in pathophysiology of various respiratory diseases, towards developing effective therapeutic strategies in the management and treatment of lung disease. It also covers promising advances in the field of therapeutics that could lead to novel clinical therapies capable of preventing or reversing the disease features including novel strategies for targeting chronic lung diseases using advanced drug delivery systems. Importantly, the book examines the significance and relevance of the plant extracts and their constituents with therapeutic efficiencies against lung diseases. As such, the book offers a blend of translational, biological, chemical, and drug delivery aspects relevant to respiratory diseases, thus, offering a valuable resource for pulmonologists and translational researchers working in the field of pulmonary biology and respiratory medicine.

Chapter 1. Introduction to Lung Diseases.- Chapter 2. Targeting molecular and cellular mechanisms in asthma.-Chapter 3. Various cellular and molecular axis involved in the pathogenesis of asthma.- Chapter 4. Targeting molecular and cellular mechanisms in steroid resistant asthma.- Chapter 5. Targeting molecular and cellular mechanisms in chronic obstructive pulmonary disease.- Chapter 6. Probing the cellular and molecular mechanisms underlying in the pathogenesis of Chronic Obstructive Pulmonary Disease (COPD).- Chapter 7. Chronic obstructive pulmonary disease: Molecular basis of pathogenesis and targeted therapeutic approaches.- Chapter 8. Exploring the dormancy-activation switch in the tumour microenvironment for metastatic lung cancer: The possible role lC—

Add Review